Pioneered Cross-functional Collaboration- Spearheaded a multidisciplinary team of engineers, scientists, and bioinformaticians to successfully develop and validate a high-impact genomics product in a record-breaking 105 days, significantly contributing to the company's growth potential and client satisfaction.Innovation Driver- Initiated and led multiple projects, translating complex scientific requirements into actionable insights for engineers and bioinformaticians. Successfully developed three products and readied for global transfer.Strategic Turnaround- Revamped a critical assay development strategy facing significant delays, overcoming technical challenges, and successfully preparing the product for validation, showcasing a knack for solving complex problems and driving progress.Product Development Insight- Proactively surveyed client needs and technology trends, leading to strategic purchases and budget allocations that positioned the company at the forefront of genomics innovation.Talent Cultivation- Hired, trained, and mentored a team of scientists, empowering them to independently develop and validate automation methods, accelerating project timelines and preparing for future innovation.

Market Research & Strategic Writing- Spearheaded comprehensive biotech industry market analysis, pinpointing critical trends and high-potential growth opportunities.- Contributed industry analysis newspaper articles and co-authored an upcoming market trend book for industry stakeholders.Scientific Advisor & Innovation Consultant- Delivered strategic advisory services to early-stage biotech startups, driving product-market fit by aligning innovative product features with market demands.

Product Management and Development- Led the development of critical informatics tools (TaPIR, ProSE) as a product manager, collaborating across departments to streamline operations and improve data management. Recognized with the PSI Partnership Award in 2020 for contributions to business innovation.Global Project Management- Managed domestic and international outsourcing projects with an annual budget of $1.5 million, expanding operational capacity and delivering development-ready humanized antibodies within accelerated timelines, demonstrating a strong focus on strategic business growth and operational scalability.Operational Efficiency- Led the transformation of antibody discovery workflows, implementing automation solutions that increased throughput by over 10 times. This strategic initiative significantly improved operational efficiency and supported the company’s long-term growth objectives.Capital Investment Leadership- Co-developed a fully integrated molecular discovery system in collaboration with HighRes, securing over $2 million in capital investment, underscoring a strong business acumen and the ability to drive high-value initiatives from concept to execution.High-Impact Technology Development- Developed and optimized a high-throughput hybridoma sequencing process, leveraging cutting-edge technologies to enhance operational efficiency and scalability, directly contributing to the company’s R&D capabilities.

Operational Leadership- Oversaw day-to-day operations, including laboratory management, procurement, and team coordination, ensuring smooth and efficient operations during the critical startup phase.Pioneering Product Development- Engineered a novel RNAi library utilizing bacterial systems, creating a comprehensive pan-genomic siRNA platform that addressed key market needs. This innovation positioned Boston Biomedical as a leader in molecular biology research.Cutting-Edge RNAi Research- Led research on asymmetrical interfering RNA (aiRNA), demonstrating superior efficacy and reduced off-target effects, directly contributing to the development of next-generation RNAi technologies and expanding the company’s product portfolio.

Therapeutic use of RNAi in treating hepatitis B and C virusDeveloped liver specific siRNA delivery system using apolipoprotein A1 peptide